Abstract
Comparison of Survival Outcomes Among Patients Receiving Chemotherapy with Secondary Cytoreductive Surgery Versus Chemotherapy Alone for Recurrent Epithelial Ovarian, Tubal, or Peritoneal Carcinoma: a Propensity Score-matched Cohort Study
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have